Surg Endosc10 Nov 2023
A systematic scoping review explored the role of intraoperative pancreatoscopy (IOP) in the surgical management of intraductal papillary mucinous neoplasms (IPMN) in the pancreas. IOP allows for the visualization of the main pancreatic duct, aiding in surgical planning. The review of five studies revealed IOP…
J Gastrointest Surg9 Nov 2023
This study delves into the impact of surgical approach on the 30-day outcomes of pancreatic cancer patients after neoadjuvant treatment (NAT). Researchers compared minimally invasive pancreatoduodenectomy (MIPD) and open pancreatoduodenectomy (OPD) within NAT groups. Among the 5,588 patients analyzed, MIPD after neoadjuvant chemotherapy alone resulted…
Ann Surg Oncol8 Nov 2023
For those facing surgery for perihilar cholangiocarcinoma (pcca), concerns about hepatic steatosis and fibrosis were investigated. Analyzing data from 401 patients, researchers found that neither hepatic steatosis nor fibrosis were associated with postoperative outcomes, including posthepatectomy liver failure (phlf) or 90-day mortality. Instead, factors like…
HPB & Spleen8 Nov 2023
This systematic review and meta-analysis delved into the world of pancreatic cancer, focusing on frailty. Among 35,191 patients, they discovered that 45% of pancreatic cancer patients were frail. This frailty took a toll, significantly reducing their chances of survival. While the results displayed some variation,…
Hernia8 Nov 2023
After analyzing data from the Herniamed registry, which included patients who underwent incisional hernia repair following pancreatic surgery, researchers found that both open and minimally invasive techniques were effective and safe, with low recurrence rates. Of the patients with one-year follow-up, 95% had previously undergone…
Ann Surg Oncol7 Nov 2023
Researchers explored the impact of hepatopancreaticoduodenectomy (HPD), a radical surgery for biliary carcinoma, on survival in patients with widespread cancer. Of the 54 patients who underwent HPD, 89% achieved R0 resection, significantly improving survival with a median of 36.9 months. Pathological portal vein involvement was…
J Surg Res7 Nov 2023
A study exploring the surgical treatment of resectable pancreatic adenocarcinoma in minority serving hospitals (MSH) revealed significant disparities. Patients at MSH were less likely to undergo surgical resection, facing unique barriers, and leading to increased mortality among those who did. These findings highlight the urgent…
Hepatology6 Nov 2023
A multicenter study harnessed Magnetic Resonance Elastography (MRE) to create a prediction model for hepatic decompensation in Non-Alcoholic Fatty Liver Disease (NAFLD) patients. This model, which combines MRE data with clinical factors like age, albumin, aspartate aminotransferase, and platelets, demonstrated excellent accuracy in forecasting the…
BMJ Open6 Nov 2023
To enhance the precision of small liver tumor removal, a phase II study in Japan will evaluate preoperative marking's effectiveness. Patients with liver tumors ≤15 mm requiring hepatectomy will undergo microcoil placement near the tumor using either the percutaneous or transvascular approach. The study aims…
HPB & Spleen6 Nov 2023
In a network meta-analysis of ten randomized controlled trials, researchers assessed the effectiveness of endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) in addition to medical management for abdominal pain in unresectable pancreatic cancer. Results favored EUS-CPN combined with medical management, showing significantly reduced pain intensity at…